Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced − Highlights Phase 2 data for ATH434 in Multiple System Atrophy (MSA) strengthened by additional analyses and ...
Neuroinflammation represents a hallmark of many degenerative diseases, such as Alzheimer’s Disease, Parkinson’s Disease, amyotrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and ...
For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a ...
Research studying the effects of cannabis on the brain has often focused on adolescents, but a new study from CU Anschutz ...
X FACTOR legend Chico Slimani has revealed how he bounced back from “losing everything” after falling victim to a Dubai ...
Khaleej Times on MSN
Novartis deepens commitment to the UAE as pharmaceutical market set to double by 2033
The UAE is rapidly consolidating its position as a global pharmaceutical and life sciences hub, with the national market ...
Detailed price information for Alterity Therapeutics Limited (PRNAF) from The Globe and Mail including charting and trades.
After witnessing my father’s tortuous battle with the illness I wanted to understand my own risk, so I visited a brain expert ...
Your organs are constantly talking to each other in ways we’re only beginning to understand. Tapping into these communication ...
As NASA readies itself for the Artemis II mission to the moon, experts have revealed everything that could go wrong on the daring space voyage.
ZipBio, a biotechnology company pioneering AI-driven protein therapeutics, announced an exclusive license agreement with MeiraGTx Holdings plc , a vertically integrated, clinical-stage genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results